The need for a disease-specific prospective pregnancy registry for multiple sclerosis (MS)

Multiple Sclerosis and Related Disorders

Volumn 4, Issue 1, 2015, Pages 6-17

  Alwan, Sura ^a   Chambers, Christina D ^b   Armenti, Vincent T ^c,d   Sadovnick, A Dessa ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c National Transplantation Pregnancy Registry   (United States)

^d UNIVERSITY OF CENTRAL FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Birth outcome; Multiple sclerosis; Pregnancy; Pregnancy registry; Reproduction

Indexed keywords

BETA INTERFERON; CORTICOSTEROID; FINGOLIMOD; GLATIRAMER; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; NATALIZUMAB; IMMUNOLOGIC FACTOR;

ARTICLE; DRUG EXPOSURE; DRUG RESPONSE; DRUG SAFETY; EPIDEMIOLOGICAL DATA; HEALTH STATUS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFORMATION STORAGE; LACTATION; MEDICAL INFORMATION; MULTIPLE SCLEROSIS; NONHUMAN; POSTMARKETING SURVEILLANCE; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY REGISTRY; REPRODUCTIVE HEALTH; TREATMENT OUTCOME; COMPLICATION; FEMALE; PREGNANCY COMPLICATION; REGISTER;

FEMALE; HUMANS; IMMUNOLOGIC FACTORS; MULTIPLE SCLEROSIS; PREGNANCY; PREGNANCY COMPLICATIONS; REGISTRIES;

EID: 84920675886     PISSN: 22110348     EISSN: 22110356     Source Type: Journal    
DOI: 10.1016/j.msard.2014.10.001     Document Type: Review

References (82)

1. A. Achiron, I. Kishner, M. Dolev, Y. Stem, M. Dulitzky, E. Schiff, and R. Achiron Effect of intravenous immunoglobulin treatment on pregnancy and postpartum-related relapses in multiple sclerosis J Neurol 251 2004 1133 1137
2. Agency for Health Research and Quality Registries for Evaluating Patients Outcomes: A Users Guide. Agency for Health Research and Quality; 2014.
3. M.P. Amato, E. Portaccio, and A. Ghezzi Pregnancy and fetal outcomes after interferon-beta exposure in multiple sclerosis Neurology 75 2010 1794 1802
4. M.T. Anderka, A.E. Lin, D.N. Abuelo, A.A. Mitchell, and S.A. Rasmussen Reviewing the evidence for mycophenolate mofetil as a new teratogen: case report and review of the literature Am J Med Genet A 149A 2009 1241 1248
5. V.T. Armenti, S. Constantinescu, M.J. Moritz, and J.M. Davison Pregnancy after transplantation Transpl Rev (Orlando) 22 2008 223 240
6. R. Boskovic, R. Wide, J. Wolpin, D. Bauer, and G. Koren The reproductive effects of beta interferon therapy in pregnancy: a longitudinal cohort Neurology 65 2005 807 811
7. Bove R, Alwan S, Friedman JM, Hellwig K, Houtchens M, Koren G et al. Management of multiple sclerosis in pregnancy and the reproductive years: A multidisciplinary review. Obstetrics and Gynecology (In press).
8. J.C. Carey, L. Martinez, E. Balken, M. Leen-Mitchell, and J. Robertson Determination of human teratogenicity by the astute clinician method: review of illustrative agents and a proposal of guidelines Birth Defects Res A: Clin Mol Teratol 85 2009 63 68
9. S.L. Carmichael, and G.M. Shaw Maternal corticosteroid use and risk of selected congenital anomalies Am J Med Genet 86 1999 242 244
10. C.D. Chambers, S.R. Braddock, and G.G. Briggs Postmarketing surveillance for human teratogenicity: a model approach Teratology 64 2001 252 261
11. Y.H. Chen, H.L. Lin, and H.C. Lin Does multiple sclerosis increase risk of adverse pregnancy outcomes? A population-based study Mult Scler 15 2009 606 612
12. B.J. Cleary, and B. Kallen Early pregnancy azathioprine use and pregnancy outcomes Birth Defects Res A: Clin Mol Teratol 85 2009 647 654
13. L.A. Coscia, S. Constantinescu, and M.J. Moritz Report from the National Transplantation Pregnancy Registry (NTPR): outcomes of pregnancy after transplantation Clin Transpl 17 Suppl 10 2010 65 85
14. P.K. Coyle, S.M. Sinclair, A.E. Scheuerle, J.M. Thorp Jr, J.D. Albano, and M.J. Rametta Final results from the Betaseron (interferon beta-1b) Pregnancy Registry: a prospective observational study of birth defects and pregnancy-related adverse events BMJ Open 4 2014 e004536
15. ® (interferon beta-1b) pregnancy registry cooperative meeting of CMSC and ACTRIMS. Orlando, Florida, USA; 2013. p. SC06.
16. P.K. Coyle, K. Johnson, Y. Stark, and L. Pardo Pregnancy outcomes in patients with multiple sclerosis treated with glatiramer acetate (Copaxone) J Neurol Neurosurg Psychiatry 74 2003 443 (poster)
17. Cristiano L, Bozic C, Kooijmans M. Preliminary evaluation of pregnancy outcomes from Tysbari (nat) pregnancy registry. In: Proceedings of the fifth joint triennial congress of the European and the Americas committees for treatment and research in multiple sclerosis; 2011. p. P1005.
18. J. Dahl, K.M. Myhr, A.K. Daltveit, J.M. Hoff, and N.E. Gilhus Pregnancy, delivery, and birth outcome in women with multiple sclerosis Neurology 65 2005 1961 1963
19. J. Dahl, K.M. Myhr, A.K. Daltveit, and N.E. Gilhus Pregnancy, delivery and birth outcome in different stages of maternal multiple sclerosis J Neurol 255 2008 623 627
20. V. De Las Heras, C. De Andres, N. Tellez, and M. Tintore Pregnancy in multiple sclerosis patients treated with immunomodulators prior to or during part of the pregnancy: a descriptive study in the Spanish population Mult Scler 13 2007 981 984
21. M. De Santis, G. Straface, A.F. Cavaliere, P. Rosati, A.P. Batocchi, and A. Caruso The first case of mitoxantrone exposure in early pregnancy Neurotoxicology 28 2007 696 697
22. J. de Seze, M. Chapelotte, S. Delalande, D. Ferriby, T. Stojkovic, and P. Vermersch Intravenous corticosteroids in the postpartum period for reduction of acute exacerbations in multiple sclerosis Mult Scler 10 2004 596 597
23. A.E. Donnenfeld, A. Pastuszak, J.S. Noah, B. Schick, N.C. Rose, and G. Koren Methotrexate exposure prior to and during pregnancy Teratology 49 1994 79 81
24. N. Ebrahimi, S. Herbstritt, R. Gold, L. Amezcua, G. Koren, and K. Hellwig Pregnancy and fetal outcomes following natalizumab exposure in pregnancy. A prospective, controlled observational study Mult Scler 2014 Epub ahead of print
25. G.M. Enns, E. Roeder, R.T. Chan, Z. Ali-Khan Catts, V.A. Cox, and M. Golabi Apparent cyclophosphamide (cytoxan) embryopathy: a distinct phenotype? Am J Med Genet 86 1999 237 241
26. N. Fernandez Liguori, D. Klajn, and L. Acion Epidemiological characteristics of pregnancy, delivery, and birth outcome in women with multiple sclerosis in Argentina (EMEMAR study) Mult Scler 15 2009 555 562
27. A. Finkelsztejn, Y.D. Fragoso, and M.L. Ferreira The Brazilian database on pregnancy in multiple sclerosis Clin Neurol Neurosurg 113 2011 277 280
28. Y.D. Fragoso, A. Finkelsztejn, and D.R. Kaimen-Maciel Long-term use of glatiramer acetate by 11 pregnant women with multiple sclerosis: a retrospective, multicentre case series CNS Drugs 24 2010 969 976
29. B.S. Giesser Immunosuppressive and novel therapies B.S. Giesser, Primer on multiple sclerosis 2011 Oxford University Press Oxford 349 368
30. M. Giannini, E. Portaccio, and A. Ghezzi Pregnancy and fetal outcomes after Glatiramer Acetate exposure in patients with multiple sclerosis: a prospective observational multicentric study BMC Neurol 12 2012 124
31. J. Haas, and O.R. Hommes A dose comparison study of IVIG in postpartum relapsing-remitting multiple sclerosis Mult Scler 13 2007 900 908
32. A. Haghikia, A. Langer-Gould, and G. Rellensmann Natalizumab use during the third trimester of pregnancy JAMA Neurol 71 2014 891 895
33. K. Hellwig, N. Brune, and A. Haghikia Reproductive counselling, treatment and course of pregnancy in 73 German MS patients Acta Neurol Scand 118 2008 24 28
34. K. Hellwig, C. Beste, S. Schimrigk, and A. Chan Immunomodulation and postpartum relapses in patients with multiple sclerosis Ther Adv Neurol Disord 2 2009 7 11
35. K. Hellwig, S. Schimrigk, A. Chan, J. Epplen, and R. Gold A newborn with Pierre Robin sequence after preconceptional mitoxantrone exposure of a female with multiple sclerosis J Neurol Sci 307 2011 164 165
36. K. Hellwig, A. Haghikia, and R. Gold Pregnancy and natalizumab: results of an observational study in 35 accidental pregnancies during natalizumab treatment Mult Scler 17 2011 958 963
37. K. Hellwig, A. Haghikia, M. Rockhoff, and R. Gold Multiple sclerosis and pregnancy: experience from a nationwide database in Germany Ther Adv Neurol Disord 5 2012 247 253
38. S. Hernandez-Diaz, C.R. Smith, and A. Shen Comparative safety of antiepileptic drugs during pregnancy Neurology 78 2012 1692 1699
39. L.B. Holmes, R. Mittendorf, A. Shen, C.R. Smith, and S. Hernandez-Diaz Fetal effects of anticonvulsant polytherapies: different risks from different drug combinations Arch Neurol 68 2011 1275 1281
40. L.B. Holmes, D.F. Wyszynski, and E. Lieberman The AED (antiepileptic drug) pregnancy registry: a 6-year experience Arch Neurol 61 2004 673 678
41. L.B. Holmes, E.J. Baldwin, and C.R. Smith Increased frequency of isolated cleft palate in infants exposed to lamotrigine during pregnancy Neurology 70 2008 2152 2158
42. A. Jalkanen, A. Alanen, and L. Airas Pregnancy outcome in women with multiple sclerosis: results from a prospective nationwide study in Finland Mult Scler 16 2010 950 955
43. V. James, F. Chiccarelli, and W. Dougherty Preclinical toxicology studies on mitoxantrone and bisantrene M. Rozencwieg, D.D. Van Hoff, M.J. Staquet, New anticancer drugs: mitoxantrone and bisantrene p 1983 Raven Press New York 47 69
44. G. Karlsson, G. Francis, and G. Koren Pregnancy outcomes in the clinical development program of fingolimod in multiple sclerosis Neurology 82 8 2014 674 680
45. D. Karussis The diagnosis of multiple sclerosis and the various related demyelinating syndromes: a critical review J Autoimmun 48-49 2014 134 142
46. V.M. Kelly, L.M. Nelson, and E.F. Chakravarty Obstetric outcomes in women with multiple sclerosis and epilepsy Neurology 73 2009 1831 1836
47. B. Kieseier, M. Benamor, H. Benzerdjeb, and O. Stuve Pregnancy outcomes from teriflunomide clinical development programme: retrospective analysis fo the teriflunomide clinical trial database Mult Scler 18 2012 P737
48. E. Lu, B.W. Wang, C. Guimond, A. Synnes, D. Sadovnick, and H. Tremlett Disease-modifying drugs for multiple sclerosis in pregnancy: a systematic review Neurology 79 2012 1130 1135
49. V. Langagergaard, L. Pedersen, M. Gislum, B. Norgard, and H.T. Sorensen Birth outcome in women treated with azathioprine or mercaptopurine during pregnancy: a Danish nationwide cohort study Aliment Pharmacol Ther 25 2007 73 81
50. M.E. Lloyd, M. Carr, P. McElhatton, G.M. Hall, and R.A. Hughes The effects of methotrexate on pregnancy, fertility and lactation Q J Med 92 1999 551 563
51. E. Lu, L. Dahlgren, A. Sadovnick, A. Sayao, A. Synnes, and H. Tremlett Perinatal outcomes in women with multiple sclerosis exposed to disease-modifying drugs Mult Scler 18 2012 460 467
52. WI McDonald, A Compston, and G Edan Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis Ann Neurol 50 2001 121 127
53. B.A. Mueller, J. Zhang, and C.W. Critchlow Birth outcomes and need for hospitalization after delivery among women with multiple sclerosis Am J Obstet Gynecol 186 2002 446 452
54. National Clinical Advisory Board of the National Multiple Sclerosis Society. National Multiple Sclerosis Society (NMSS) Disease Management Consensus Statement. ?www.nmss.org?; 2007 [accessed 24.04.11].
55. R. Orvieto, R. Achiron, Z. Rotstein, S. Noy, I. Bar-Hava, and A. Achiron Pregnancy and multiple sclerosis: a 2-year experience Eur J Obstet Gynecol Reprod Biol 82 1999 191 194
56. T.R. Ozolins Cyclophosphamide and the Teratology Society: an awkward marriage Birth Defects Res B: Dev Reprod Toxicol 89 2010 289 299
57. F. Patti, T. Cavallaro, and S. Lo Fermo Is in utero early-exposure to interferon beta a risk factor for pregnancy outcomes in multiple sclerosis? J Neurol 255 2008 1250 1253
58. J.E. Polifka, and J.M. Friedman Teratogen update: azathioprine and 6-mercaptopurine Teratology 65 2002 240 261
59. C.H. Polman, S.C. Reingold, and G. Edan Diagnostic criteria for multiple sclerosis: 2005 revisions to the McDonald Criteria Ann Neurol 58 2005 840 846
60. C.H. Polman, S.C. Reingold, and B. Banwell Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria Ann Neurol 69 2011 292 302
61. S. Poser, and W. Poser Multiple sclerosis and gestation Neurology 33 1983 1422 1427
62. P. Pradat, E. Robert-Gnansia, G.L. Di Tanna, A. Rosano, A. Lisi, and P. Mastroiacovo First trimester exposure to corticosteroids and oral clefts Birth Defects Res A: Clin Mol Teratol 67 2003 968 970
63. ® Pregnancy Registry. EMD Serono; 2013.
64. ® (Intramuscular Interferon Beta-1a) Pregnancy Exposure Registry Neurology 78 2012 P06 P191 (Meeting Abstracts 1)
65. E. Roullet, M.H. Verdier-Taillefer, P. Amarenco, G. Gharbi, A. Alperovitch, and R. Marteau Pregnancy and multiple sclerosis: a longitudinal study of 125 remittent patients J Neurol Neurosurg Psychiatry 56 1993 1062 1065
66. E. Rodriguez-Pinilla, and M.L. Martinez-Frias Corticosteroids during pregnancy and oral clefts: a case-control study Teratology 58 1998 2 5
67. A.D. Sadovnick, K. Eisen, and S.A. Hashimoto Pregnancy and multiple sclerosis. A prospective study Arch Neurol 51 1994 1120 1124
68. J.E. Sanders, J. Hawley, and W. Levy Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation Blood 87 1996 3045 3052
69. M. Sandberg-Wollheim, E. Alteri, M.S. Moraga, and G. Kornmann Pregnancy outcomes in multiple sclerosis following subcutaneous interferon beta-1a therapy Mult Scler 17 2011 423 430
70. H.J. Salminen, H. Leggett, and M. Boggild Glatiramer acetate exposure in pregnancy: preliminary safety and birth outcomes J Neurol 257 2010 2020 2023
71. A.R. Scialli The Organization of Teratology Information Services (OTIS) Registry Study J Allergy Clin Immunol 103 1999 S373 S376
72. J. Shaner, L.A. Coscia, and S. Constantinescu Pregnancy after lung transplant Prog Transpl 22 2012 134 140
73. N.M. Sifontis, L.A. Coscia, S. Constantinescu, A.F. Lavelanet, M.J. Moritz, and V.T. Armenti Pregnancy outcomes in solid organ transplant recipients with exposure to mycophenolate mofetil or sirolimus Transplantation 82 2006 1698 1702
74. The IFNB Multiple Sclerosis Study Group Interferon beta-1b is effective in relapsing-remitting multiple sclerosis I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial Neurology 43 1993 655 661
75. The IFNB Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group Interferon beta-1b in the treatment of multiple sclerosis: final outcome of the randomized controlled trial Neurology 45 1995 1277 1285
76. The North American Antiepileptic Drug Pregnancy Registry. ?http://www2massgeneralorg/aed/abouthtm?; 2012.
77. K.M. Thiagarajan, S.R. Arakali, and K.J. Mealey Safety considerations: breastfeeding after transplant Prog Transplant 23 2013 137 146
78. M.L. van der Kop, M.S. Pearce, and L. Dahlgren Neonatal and delivery outcomes in women with multiple sclerosis Ann Neurol 70 2011 41 50
79. R. Voskuhl, and B.S. Giesser Gender and Reprodutive Issues in Multiple Sclerosis B.S. Giesser, Primer on multiple sclerosis 2011 Oxford University Press New York 221 240
80. C Weber-Schoendorfer, and C. Schaefer Multiple sclerosis, immunomodulators, and pregnancy outcome: a prospective observational study Mult Scler 15 2009 1037 1042
81. J. Worthington, R. Jones, M. Crawford, and A. Forti Pregnancy and multiple sclerosis - a 3-year prospective study J Neurol 241 1994 228 233
82. D.F. Wyszynski, M. Nambisan, T. Surve, R.M. Alsdorf, C.R. Smith, and L.B. Holmes Increased rate of major malformations in offspring exposed to valproate during pregnancy Neurology 64 2005 961 965